Educational guide
Adamax Overview, Dosing & Safety | Peptide Database
Adamax Next-Generation Semax Derivative | Nootropic Neuropeptide Community Research Join others researching Adamax — share findings, ask questions, and learn from real experiences Synthetic nootropic peptide with N-terminal acetylation and C-terminal adamantan
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Adamax
Next-Generation Semax Derivative | Nootropic Neuropeptide
Community Research
Join others researching Adamax — share findings, ask questions, and learn from real experiences
Synthetic nootropic peptide with N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration, researched for cognitive enhancement, neuroprotection, and neuroplasticity.
Crosses BBB via enhanced lipophilicity from adamantane; upregulates BDNF and TrkB receptor sensitivity; modulates dopamine, norepinephrine, and serotonin; stabilizes microtubules via ADNP-derived mechanisms; provides antioxidant and anti-inflammatory neuroprotection.
Molecular Data
Ac
Position 1
Methionine
Position 2
Glutamic Acid
Position 3
Histidine
Position 4
Phenylalanine
Position 5
Proline
Position 6
Glycine
Position 7
Position 8
AGly
Position 9
NH2
Position 10
Research Indications
Preliminary research suggests improvements in focus, mental clarity, memory consolidation, and complex task handling.
BDNF upregulation and TrkB enhancement promote new neural connections and synaptic plasticity for long-term improvements.
May enhance memory formation, information retention, and learning efficiency through hippocampal BDNF-TrkB pathway activation.
Preliminary observations indicate improved neurological outcomes through oxidative stress reduction and neuronal repair.
Demonstrates antioxidant properties protecting against oxidative damage and inflammation-induced neuronal injury.
Supports neuronal survival and growth through BDNF enhancement and microtubule stabilization.
Influences serotonin and dopamine to elevate mood and reduce depressive symptoms through neurotransmitter modulation.
Anecdotal reports indicate reduced overwhelm and anxiety through balanced neurotransmitter activity.
HPA axis modulation may improve stress response and emotional well-being.
Dosing Protocols
Enhanced cognitive function and neuroprotection through direct systemic delivery with superior bioavailability.
Cognitive Enhancement
200-300mcg
1x daily
SubQ
Neuroprotection
300mcg
1-2x daily
Mood Support
200mcg
1x daily (morning)
Initial Trial
100-200mcg
Reconstitution Instructions
Bacteriostatic water (BAC)
Insulin syringes (0.5-1mL)
Alcohol swabs
Peptide vial
Sterile work surface
1 Clean work area and hands thoroughly with alcohol
2 Calculate required BAC water volume using calculator
3 Draw calculated BAC water into syringe
4 Inject slowly down vial side (not directly onto powder)
5 Gently swirl until completely dissolved (never shake vigorously)
6 Store reconstituted solution in refrigerator at 2-8°C
7 Use within 14-30 days for optimal potency
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
Headaches (particularly at higher doses)
Insomnia or sleep disruption
Anxiety or overstimulation
Cardiovascular effects (elevated blood pressure, palpitations)
Stop Signs - Discontinue if:
Persistent or severe headaches
Chest pain, heart palpitations, or significant blood pressure increases
Severe anxiety, insomnia, or mood disturbances
Unusual neurological symptoms or mental status changes
Persistent injection site reactions or infection signs
Gastrointestinal distress (nausea, vomiting, diarrhea)
Contraindications
Pregnancy and breastfeeding
Cardiovascular conditions (without medical supervision)
Severe anxiety disorders
Uncontrolled hypertension
Quality Checklist
Good Signs
White, fluffy powder indicating proper freeze-drying
Clear solution after reconstitution with no particles or cloudiness
Proper labeling with peptide name, batch number, manufacturing date
Warning Signs
Slight compaction from shipping acceptable if powder dissolves completely
Bad Signs
Discoloration or yellowing indicates oxidation or degradation
Persistent cloudiness or particles indicate degradation or contamination
Frequently Asked Questions
How does Adamax improve cognition differently than Semax?
Adamax is a next-generation Semax derivative with C-terminal adamantane modification for enhanced lipophilicity and blood-brain barrier penetration. While parent Semax shows cognitive benefits, Adamax's superior stability and BBB crossing potentially enable stronger cognitive effects at lower doses and with more sustained action.
Can Adamax cause overstimulation if combined with other nootropics?
Yes. Adamax shares BDNF upregulation with compounds like Noopept, so combining them risks excessive neurotropic effects. Start with lower doses and monitor for overstimulation, anxiety, or sleep disruption. Safe stacking requires careful dose titration and might be better avoided for most users.
What causes the headaches some people report on Adamax?
Headaches are most common at higher doses (particularly above 300mcg). This likely relates to the potent dopamine, norepinephrine, and serotonin modulation combined with BDNF upregulation creating temporary neurochemical shifts. Starting at 100-200mcg and titrating slowly minimizes this risk.
How long do Adamax's cognitive effects last after stopping?
Due to BDNF-mediated neuroplasticity improvements, cognitive benefits persist weeks or months beyond discontinuation. Peak neuroprotective and structural brain benefits appear by week 4+ with continuous use, but the neuronal changes induced by BDNF upregulation have lasting effects independent of the compound remaining in circulation.
References
Foundational Semax review: intranasal doses stimulate operative memory and attention for 20-24 hours. Adamax builds on the Semax core sequence with adamantane modification for enhanced stability and BBB penetration.
Single application at 50 mcg/kg produced 1.4-fold increase in BDNF protein and 1.6-fold increase in trkB tyrosine phosphorylation in rat hippocampus, supporting Adamax's BDNF-TrkB mechanism.
110 ischemic stroke patients; Semax (6000 mcg/day intranasal) increased BDNF plasma levels and accelerated functional recovery, providing the clinical basis for Adamax neuroprotective applications.
Genome-wide analysis: Semax modulated 24 vascular genes at 3h and enhanced immune-response gene expression at 24h post-ischemia, demonstrating multi-pathway neuroprotection.
Related Peptides
Adamax is an enhanced derivative with improved stability and bioavailability.
Adamax incorporates adamantyl portion from P21; may complement cognitive benefits.
Different mechanisms—Adamax targets neurological function; BPC-157 focuses on tissue repair.
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.